Structure-based design of peptides that self-assemble into regular polyhedral nanoparticles

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 2, Issue 2, 2006, Pages 95-102

  Raman, Senthilkumar ^a   Machaidze, Gia ^a   Lustig, Ariel ^a   Aebi, Ueli ^a   Burkhard, Peter ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Antigen display; Drug delivery; Drug targeting; Peptide nanoparticles; Protein design

Indexed keywords

ANTIGEN DISPLAY; DRUG DELIVERY; DRUG TARGETING; PEPTIDE NANOPARTICLES; PROTEIN DESIGN;

ANTIGENS; CONTROLLED DRUG DELIVERY; MEDICAL APPLICATIONS; NANOSTRUCTURED MATERIALS; POLYMERS; SELF ASSEMBLY;

AMINO ACIDS;

LIPOSOME; NANOPARTICLE; PEPTIDE;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL COMPOSITION; COMPUTER AIDED DESIGN; COMPUTER MODEL; DRUG DELIVERY SYSTEM; DRUG TARGETING; OLIGOMERIZATION; PARTICLE SIZE; PROTEIN ASSEMBLY; PROTEIN SYNTHESIS; SOLID; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; COMPUTATIONAL BIOLOGY; DRUG DESIGN; MICROSCOPY, ELECTRON; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; NANOPARTICLES; PEPTIDES; PROTEIN FOLDING; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; ULTRACENTRIFUGATION;

EID: 33745453385     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2006.04.007     Document Type: Article

References (37)

1. Langer R. Drug delivery and targeting. Nature 392 (1998) 5-10
2. Kiser P.F., Wilson G., and Needham D. A synthetic mimic of the secretory granule for drug delivery. Nature 394 (1998) 459-462
3. Ong S., Liu H., Qiu X., Bhat G., and Pidgeon C. Membrane partition coefficients chromatographically measured using immobilized artificial membrane surfaces. Anal Chem 67 (1995) 755-762
4. Rogers J.A., and Choi Y.W. The liposome partitioning system for correlating biological activities of imidazolidine derivatives. Pharm Res 10 (1993) 913-917
5. Savic R., Luo L., Eisenberg A., and Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 300 (2003) 615-618
6. Allen T.M., and Cullis P.R. Drug delivery systems: entering the mainstream. Science 303 (2004) 1818-1822
7. Meier W. Polymer nanocapsules. Chem Soc Rev 29 (2000) 295-303
8. Tabata M., Kondo M., Haruta Y., and Seon B.K. Antiangiogenic radioimmunotherapy of human solid tumors in SCID mice using 125I-labeled anti-endoglin monoclonal antibodies. Int J Cancer 82 (1999) 737-742
9. Arap W., Pasqualini R., and Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279 (1998) 377-380
10. Berzofsky J.A., Ahlers J.D., Derby M.A., Pendleton C.D., Arichi T., and Belyakov I.M. Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections. Immunol Rev 170 (1999) 151-172
11. Lechmann M., and Liang T.J. Vaccine development for hepatitis C. Semin Liver Dis 20 (2000) 211-226
12. Paul W.E. Can the immune response control HIV infection?. Cell 82 (1995) 177-182
13. Gahery-Segard H., Pialoux G., Charmeteau B., Sermet S., Poncelet H., et al. Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine. J Virol 74 (2000) 1694-1703
14. Gras-Masse H. Single-chain lipopeptide vaccines for the induction of virus-specific cytotoxic T cell responses in randomly selected populations. Mol Immunol 38 (2001) 423-431
15. Hoffman S.L., Subramanian G.M., Collins F.H., and Venter J.C. Plasmodium, human and Anopheles genomics and malaria. Nature 415 (2002) 702-709
16. Wang J., Zganiacz A., and Xing Z. Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulation. Vaccine 20 (2002) 2887-2898
17. Hayman W.A., Toth I., Flinn N., Scanlon M., and Good M.F. Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology. Immunol Cell Biol 80 (2002) 178-187
18. Nesburn A.B., Burke R.L., Ghiasi H., Slanina S.M., and Wechsler S.L. Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus in latently infected rabbits. Virology 252 (1998) 200-209
19. Wareing M.D., and Tannock G.A. Influenza update: vaccine development and clinical trials. Curr Opin Pulm Med 8 (2002) 209-213
20. Parmiani G., Castelli C., Dalerba P., Mortarini R., Rivoltini L., et al. Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?. J Natl Cancer Inst 94 (2002) 805-818
21. Van Regenmortel M.H. Antigenicity and immunogenicity of synthetic peptides. Biologicals 29 (2001) 209-213
22. BenMohamed L., Wechsler S.L., and Nesburn A.B. Lipopeptide vaccines-yesterday, today, and tomorrow. Lancet Infect Dis 2 (2002) 425-431
23. Johnson J.E., and Reddy V.S. Biggest virus molecular structure yet!. Nat Struct Biol 5 (1998) 849-854
24. Padilla J.E., Colovos C., and Yeates T.O. Nanohedra: using symmetry to design self assembling protein cages, layers, crystals, and filaments. Proc Natl Acad Sci USA 98 (2001) 2217-2221
25. Burkhard P., Strelkov S.V., and Stetefeld J. Coiled coils: a highly versatile protein folding motif. Trends Cell Biol 11 (2001) 82-88
26. Lupas A. Coiled coils: new structures and new functions. Trends Biochem Sci 21 (1996) 375-382
27. O'Shea E.K., Klemm J.D., Kim P.S., and Alber T. X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil. Science 254 (1991) 539-544
28. Tao Y., Strelkov S.V., Mesyanzhinov V.V., and Rossmann M.G. Structure of bacteriophage T4 fibritin: a segmented coiled coil and the role of the C-terminal domain. Structure 5 (1997) 789-798
29. Stetefeld J., Jenny M., Schulthess T., Landwehr R., Engel J., and Kammerer R.A. Crystal structure of a naturally occurring parallel right-handed coiled coil tetramer. Nat Struct Biol 7 (2000) 772-776
30. Malashkevich V.N., Kammerer R.A., Efimov V.P., Schulthess T., and Engel J. The crystal structure of a five-stranded coiled coil in COMP: a prototype ion channel?. [see comments]. Science 274 (1996) 761-765
31. Sanner M.F., Stolz M., Burkhard P., Kong X.P., Min G., et al. Visualizing nature at work from the nano to the macro scale. Nanobiotechnology 1 (2005) 7-22
32. Burkhard P., Meier M., and Lustig A. Design of a minimal protein oligomerization domain by a structural approach. Protein Sci 9 (2000) 2294-2301
33. Burkhard P., Kammerer R.A., Steinmetz M.O., Bourenkov G.P., and Aebi U. The coiled-coil trigger site of the rod domain of cortexillin I unveils a distinct network of interhelical and intrahelical salt bridges. Structure Fold Des 8 (2000) 223-230
34. Burkhard P., Ivaninskii S., and Lustig A. Improving coiled-coil stability by optimizing ionic interactions. J Mol Biol 318 (2002) 901-910
35. Guo Y., Kammerer R.A., and Engel J. The unusually stable coiled-coil domain of COMP exhibits cold and heat denaturation in 4-6 M guanidinium chloride [in process citation]. Biophys Chem 85 (2000) 179-186
36. Fehr T., Skrastina D., Pumpens P., and Zinkernagel R.M. T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles. Proc Natl Acad Sci USA 95 (1998) 9477-9481
37. Hunter R.L. Overview of vaccine adjuvants: present and future. Vaccine 20 Suppl 3 (2002) S7-S12